Cargando…
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
BACKGROUND: Recently, there has been an increased use of recombinant activated factor VII (rFVIIa) to promote hemostasis in various hemorrhagic conditions. The objective of this study was to determine the outcome of patients treated with rFVIIa who had intractable bleeding associated with cardiac su...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535534/ https://www.ncbi.nlm.nih.gov/pubmed/15530167 http://dx.doi.org/10.1186/1477-9560-2-9 |